Retension Pharmaceuticals, Inc. (RTSN) KPIs and segments
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 18, 2026
$13.89+2.48 (+21.74%)
Close on Nov 18, 2026Market cap $11.22MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Retension Pharmaceuticals's business
Coming soon
This tab will track the numbers specific to Retension Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?